Carmell (CTCX) Competitors $2.45 -0.07 (-2.78%) As of 07/1/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CTCX vs. PROF, INGN, ELMD, KRMD, CVRX, AVR, LNSR, PDEX, PTHL, and LAKEShould you be buying Carmell stock or one of its competitors? The main competitors of Carmell include Profound Medical (PROF), Inogen (INGN), Electromed (ELMD), KORU Medical Systems (KRMD), CVRx (CVRX), Anteris Technologies Global (AVR), LENSAR (LNSR), Pro-Dex (PDEX), Pheton (PTHL), and Lakeland Industries (LAKE). These companies are all part of the "medical equipment" industry. Carmell vs. Its Competitors Profound Medical Inogen Electromed KORU Medical Systems CVRx Anteris Technologies Global LENSAR Pro-Dex Pheton Lakeland Industries Profound Medical (NASDAQ:PROF) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends. Do insiders and institutionals hold more shares of PROF or CTCX? 47.9% of Profound Medical shares are owned by institutional investors. Comparatively, 24.2% of Carmell shares are owned by institutional investors. 1.5% of Profound Medical shares are owned by company insiders. Comparatively, 29.0% of Carmell shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media favor PROF or CTCX? In the previous week, Profound Medical had 1 more articles in the media than Carmell. MarketBeat recorded 1 mentions for Profound Medical and 0 mentions for Carmell. Profound Medical's average media sentiment score of 0.75 beat Carmell's score of 0.00 indicating that Profound Medical is being referred to more favorably in the media. Company Overall Sentiment Profound Medical Positive Carmell Neutral Which has stronger valuation & earnings, PROF or CTCX? Carmell has lower revenue, but higher earnings than Profound Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProfound Medical$10.68M16.83-$27.82M-$1.22-4.90Carmell$32.84K1,559.65-$15.44MN/AN/A Do analysts rate PROF or CTCX? Profound Medical currently has a consensus target price of $11.50, suggesting a potential upside of 92.31%. Given Profound Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Profound Medical is more favorable than Carmell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Profound Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Carmell 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility & risk, PROF or CTCX? Profound Medical has a beta of 0.49, suggesting that its share price is 51% less volatile than the S&P 500. Comparatively, Carmell has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500. Is PROF or CTCX more profitable? Carmell has a net margin of 0.00% compared to Profound Medical's net margin of -269.35%. Profound Medical's return on equity of -70.41% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets Profound Medical-269.35% -70.41% -57.22% Carmell N/A -217.50%-50.22% SummaryProfound Medical beats Carmell on 8 of the 14 factors compared between the two stocks. Get Carmell News Delivered to You Automatically Sign up to receive the latest news and ratings for CTCX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CTCX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTCX vs. The Competition Export to ExcelMetricCarmellSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$51.22M$248.27M$5.50B$9.01BDividend YieldN/AN/A5.39%4.11%P/E RatioN/A5.9127.4220.07Price / Sales1,559.6570.57398.50109.13Price / CashN/A196.1236.1356.90Price / Book2.296.138.015.70Net Income-$15.44M-$26.71M$3.16B$248.47M7 Day Performance-4.67%-1.78%2.08%2.92%1 Month Performance-25.08%-6.36%4.38%5.77%1 Year Performance40.80%24.49%35.81%21.39% Carmell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTCXCarmellN/A$2.45-2.8%N/A+36.1%$51.22M$32.84K0.0014Gap DownPROFProfound Medical2.5007 of 5 stars$6.29+4.7%$11.50+82.7%-29.0%$189.03M$11.86M-5.16150INGNInogen4.3148 of 5 stars$6.95+4.1%$11.00+58.4%-3.3%$186.75M$335.70M-6.041,030Positive NewsELMDElectromed1.227 of 5 stars$21.53+1.3%$38.00+76.5%+45.1%$180.51M$61.44M28.70160KRMDKORU Medical Systems2.2435 of 5 stars$3.57+3.9%$4.50+26.2%+60.4%$164.72M$33.65M-32.4580Positive NewsCVRXCVRx2.769 of 5 stars$5.84+2.1%$14.50+148.3%-45.2%$152.12M$51.29M-2.68160Positive NewsAVRAnteris Technologies GlobalN/A$4.06+6.8%$16.50+306.4%N/A$146.40M$2.70M0.00138News CoverageLNSRLENSAR1.3009 of 5 stars$12.39+1.2%$15.00+21.1%+203.7%$146.10M$57.07M-2.55110PDEXPro-Dex2.2489 of 5 stars$42.17+0.8%$56.00+32.8%+151.3%$137.46M$53.84M15.06140PTHLPhetonN/A$20.18+1.9%N/AN/A$132.78M$448.20K0.0011LAKELakeland Industries4.8736 of 5 stars$13.76-1.9%$26.00+88.9%-39.0%$131.33M$167.21M-4.592,100Positive News Related Companies and Tools Related Companies PROF Alternatives INGN Alternatives ELMD Alternatives KRMD Alternatives CVRX Alternatives AVR Alternatives LNSR Alternatives PDEX Alternatives PTHL Alternatives LAKE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CTCX) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carmell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carmell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.